"Protozoan Proteins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Proteins found in any species of protozoan.
| Descriptor ID |
D015800
|
| MeSH Number(s) |
D12.776.820
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Protozoan Proteins".
Below are MeSH descriptors whose meaning is more specific than "Protozoan Proteins".
This graph shows the total number of publications written about "Protozoan Proteins" by people in this website by year, and whether "Protozoan Proteins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 0 | 1 | 1 |
| 2001 | 1 | 0 | 1 |
| 2002 | 1 | 0 | 1 |
| 2003 | 1 | 1 | 2 |
| 2004 | 0 | 3 | 3 |
| 2005 | 0 | 2 | 2 |
| 2006 | 3 | 1 | 4 |
| 2007 | 3 | 1 | 4 |
| 2008 | 0 | 1 | 1 |
| 2009 | 1 | 1 | 2 |
| 2010 | 2 | 1 | 3 |
| 2011 | 2 | 2 | 4 |
| 2012 | 0 | 1 | 1 |
| 2013 | 2 | 1 | 3 |
| 2014 | 1 | 0 | 1 |
| 2015 | 9 | 0 | 9 |
| 2016 | 4 | 2 | 6 |
| 2017 | 5 | 1 | 6 |
| 2018 | 1 | 0 | 1 |
| 2019 | 1 | 4 | 5 |
| 2020 | 6 | 1 | 7 |
| 2021 | 0 | 2 | 2 |
| 2022 | 4 | 0 | 4 |
| 2023 | 0 | 2 | 2 |
| 2024 | 3 | 3 | 6 |
| 2025 | 4 | 0 | 4 |
| 2026 | 4 | 1 | 5 |
To return to the timeline,
click here.
Below are the most recent publications written about "Protozoan Proteins" by people in Profiles.
-
Reconstruction of historical malaria transmission in Senegal using multiplex serocatalytic models. PLoS Comput Biol. 2026 Jul; 22(7):e1013630.
-
MAHRP2 is required for tether formation and cytoadherence in Plasmodium falciparum infected red blood cells. Front Cell Infect Microbiol. 2026; 16:1675134.
-
Comparative proteomic profiling reveals distinct molecular signatures of drug resistance in clinical isolates of Leishmania donovani. Parasitol Int. 2026 Oct; 114:103267.
-
A Trypanosoma cruzi trans-sialidase peptide demonstrates high serological prevalence among infected populations across endemic regions. J Clin Invest. 2026 Mar 16; 136(6).
-
Immunotherapy of TSA-1.C4 or in combination with BNZ confers protection against Trypanosoma cruzi infection with a distinct cytokine response. Vaccine. 2026 Mar 19; 76:128296.
-
Manipulation of macrophage signaling by Leishmania virulence factors. Virulence. 2025 Dec; 16(1):2549802.
-
A divergent cyclic nucleotide binding protein promotes Plasmodium ookinete infection of the mosquito. PLoS Pathog. 2025 Sep; 21(9):e1013467.
-
Mutual suppression between mutations in the Dictyostelium Greenbeard pathway restores wild-type development. BMC Genomics. 2025 Jun 05; 26(1):563.
-
Fc?R binding differentially contributes to protection by two human monoclonal antibodies targeting Plasmodium falciparum circumsporozoite protein. Sci Transl Med. 2025 Apr 23; 17(795):eadk6745.
-
Immunopeptidomic MHC-I profiling and immunogenicity testing identifies Tcj2 as a new Chagas disease mRNA vaccine candidate. PLoS Pathog. 2024 12; 20(12):e1012764.